399 related articles for article (PubMed ID: 22895092)
21. Permanent farnesylation of lamin A mutants linked to progeria impairs its phosphorylation at serine 22 during interphase.
Moiseeva O; Lopes-Paciencia S; Huot G; Lessard F; Ferbeyre G
Aging (Albany NY); 2016 Feb; 8(2):366-81. PubMed ID: 26922519
[TBL] [Abstract][Full Text] [Related]
22. Lamin A precursor induces barrier-to-autointegration factor nuclear localization.
Capanni C; Cenni V; Haraguchi T; Squarzoni S; Schüchner S; Ogris E; Novelli G; Maraldi N; Lattanzi G
Cell Cycle; 2010 Jul; 9(13):2600-10. PubMed ID: 20581439
[TBL] [Abstract][Full Text] [Related]
23. Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53.
Kudlow BA; Stanfel MN; Burtner CR; Johnston ED; Kennedy BK
Mol Biol Cell; 2008 Dec; 19(12):5238-48. PubMed ID: 18843043
[TBL] [Abstract][Full Text] [Related]
24. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
25. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts.
Eisch V; Lu X; Gabriel D; Djabali K
Oncotarget; 2016 Apr; 7(17):24700-18. PubMed ID: 27015553
[TBL] [Abstract][Full Text] [Related]
26. Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome.
Gordon LB; Massaro J; D'Agostino RB; Campbell SE; Brazier J; Brown WT; Kleinman ME; Kieran MW;
Circulation; 2014 Jul; 130(1):27-34. PubMed ID: 24795390
[TBL] [Abstract][Full Text] [Related]
27. A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells.
Cao K; Capell BC; Erdos MR; Djabali K; Collins FS
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4949-54. PubMed ID: 17360355
[TBL] [Abstract][Full Text] [Related]
28. Identification of differential protein interactors of lamin A and progerin.
Kubben N; Voncken JW; Demmers J; Calis C; van Almen G; Pinto Y; Misteli T
Nucleus; 2010; 1(6):513-25. PubMed ID: 21327095
[TBL] [Abstract][Full Text] [Related]
29. Status of treatment strategies for Hutchinson-Gilford progeria syndrome with a focus on prelamin: A posttranslational modification.
Chen X; Yao H; Andrés V; Bergo MO; Kashif M
Basic Clin Pharmacol Toxicol; 2022 Oct; 131(4):217-223. PubMed ID: 35790078
[TBL] [Abstract][Full Text] [Related]
30. Imbalanced nucleocytoskeletal connections create common polarity defects in progeria and physiological aging.
Chang W; Wang Y; Luxton GWG; Östlund C; Worman HJ; Gundersen GG
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3578-3583. PubMed ID: 30808750
[TBL] [Abstract][Full Text] [Related]
31. Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndrome.
Davies BS; Yang SH; Farber E; Lee R; Buck SB; Andres DA; Spielmann HP; Agnew BJ; Tamanoi F; Fong LG; Young SG
J Lipid Res; 2009 Jan; 50(1):126-34. PubMed ID: 18757838
[TBL] [Abstract][Full Text] [Related]
32. Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.
Gabriel D; Roedl D; Gordon LB; Djabali K
Aging Cell; 2015 Feb; 14(1):78-91. PubMed ID: 25510262
[TBL] [Abstract][Full Text] [Related]
33. A-type lamins and Hutchinson-Gilford progeria syndrome: pathogenesis and therapy.
Gonzalez JM; Pla D; Perez-Sala D; Andres V
Front Biosci (Schol Ed); 2011 Jun; 3(3):1133-46. PubMed ID: 21622261
[TBL] [Abstract][Full Text] [Related]
34. An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria.
Davies BS; Barnes RH; Tu Y; Ren S; Andres DA; Spielmann HP; Lammerding J; Wang Y; Young SG; Fong LG
Hum Mol Genet; 2010 Jul; 19(13):2682-94. PubMed ID: 20421363
[TBL] [Abstract][Full Text] [Related]
35. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated.
Yang SH; Andres DA; Spielmann HP; Young SG; Fong LG
J Clin Invest; 2008 Oct; 118(10):3291-300. PubMed ID: 18769635
[TBL] [Abstract][Full Text] [Related]
36. Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry.
Camafeita E; Jorge I; Rivera-Torres J; Andrés V; Vázquez J
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233036
[TBL] [Abstract][Full Text] [Related]
37. Progerin-expressing endothelial cells are unable to adapt to shear stress.
Danielsson BE; Peters HC; Bathula K; Spear LM; Noll NA; Dahl KN; Conway DE
Biophys J; 2022 Feb; 121(4):620-628. PubMed ID: 34999130
[TBL] [Abstract][Full Text] [Related]
38. Increased plasticity of the nuclear envelope and hypermobility of telomeres due to the loss of A-type lamins.
De Vos WH; Houben F; Hoebe RA; Hennekam R; van Engelen B; Manders EM; Ramaekers FC; Broers JL; Van Oostveldt P
Biochim Biophys Acta; 2010 Apr; 1800(4):448-58. PubMed ID: 20079404
[TBL] [Abstract][Full Text] [Related]
39. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
McClintock D; Gordon LB; Djabali K
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
[TBL] [Abstract][Full Text] [Related]
40. Mapping of lamin A- and progerin-interacting genome regions.
Kubben N; Adriaens M; Meuleman W; Voncken JW; van Steensel B; Misteli T
Chromosoma; 2012 Oct; 121(5):447-64. PubMed ID: 22610065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
